XML 19 R9.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statement of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Cash flows provided by operating activities:    
Net income $ 104,779 $ 83,359
Adjustments to reconcile net income to net cash provided by operating activities:    
Amortization of discount/premium and PIK (30,192) (7,934)
Amortization of deferred financing costs 5,355 2,761
Equity-based compensation 2,628 4,921
Unrealized loss on securities 0 1,658
Provision for loan losses and impairment 5,000 5,000
Loss from unconsolidated joint venture 0 2,259
Foreign currency (gain) loss 17,371 (10,014)
Unrealized (gain) loss on derivative instruments (15,941) 10,433
Realized loss on derivative instruments 0 110
Realized loss on sale of assets 0 1,042
Changes in operating assets and liabilities:    
Proceeds received from PIK 75,652 0
Other assets (4,069) (17,734)
Accounts payable, accrued expenses and other liabilities 10,190 (5,127)
Payable to related party 845 728
Net cash (used in) provided by operating activities 171,618 71,462
Cash flows used in investing activities:    
New funding of commercial mortgage loans (1,275,507) (339,394)
Add-on funding of commercial mortgage loans (60,500) (61,296)
New funding of subordinate loans (201,966) (146,738)
Add-on funding of subordinate loans (43,284) (76,796)
Payments received on commercial mortgage loans 227,913 10,199
Payments received on subordinate loans 367,143 58,615
Funding of derivative instruments 0 (201)
Origination and exit fees received on commercial mortgage and subordinate loans 28,362 7,129
Funding of unconsolidated joint venture 0 (726)
Funding of other assets 0 (1,379)
(Increase) decrease in collateral held related to derivative contracts 4,930 (22)
Payments and proceeds received on securities 0 217,708
Proceeds from sale of investments in unconsolidated joint venture 0 24,498
Net cash (used in) provided by investing activities (952,909) (308,403)
Cash flows from financing activities:    
Proceeds from issuance of common stock 275,879 249,021
Payment of offering costs (188) (359)
Proceeds from secured debt arrangements 1,367,211 464,153
Repayments of secured debt arrangements (723,260) (272,878)
Repayments of participations sold 0 (85,081)
Payment of deferred financing costs (11,314) (5,343)
Dividends on common stock (114,655) (85,724)
Dividends on preferred stock (13,669) (18,620)
Net cash (used in) provided by financing activities 780,004 245,169
Net increase (decrease) in cash and cash equivalents (1,287) 8,228
Cash and restricted cash, beginning of period 77,671 263,453
Cash and restricted cash, end of period 76,384 271,681
Supplemental disclosure of cash flow information:    
Interest paid 43,420 11,916
Supplemental disclosure of non-cash financing activities:    
Dividend declared, not yet paid 64,162 57,464
Offering costs payable $ 265 $ 41